sylvant poudre pour solution
eusa pharma (uk) limited - siltuximab - poudre pour solution - 100mg - siltuximab 100mg - immunosuppressive agents
sylvant poudre pour solution
eusa pharma (uk) limited - siltuximab - poudre pour solution - 400mg - siltuximab 400mg - immunosuppressive agents
gd-temsirolimus solution
genmed a division of pfizer canada ulc - temsirolimus - solution - 25mg - temsirolimus 25mg - antineoplastic agents
darzalex solution
janssen inc - daratumumab - solution - 100mg - daratumumab 100mg - antineoplastic agents
darzalex solution
janssen inc - daratumumab - solution - 400mg - daratumumab 400mg - antineoplastic agents
cinqair solution
teva canada limited - reslizumab - solution - 10mg - reslizumab 10mg - interleukin antagonists
prevymis 240 mg comprimés pelliculés
msd merck sharp & dohme ag - letermovirum - comprimés pelliculés - letermovirum 240 mg, cellulosum microcristallinum, carmellosum natricum conexum, povidonum k 25, silica colloidalis anhydrica, magnesii stearas, Überzug: cera carnauba, lactosum monohydricum 3.96 mg, hypromellosum, triacetinum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 1.9 mg. - cytomegalovirus-(cmv) prophylaxe - synthetika
prevymis 480 mg comprimés pelliculés
msd merck sharp & dohme ag - letermovirum - comprimés pelliculés - letermovirum 480 mg, cellulosum microcristallinum, carmellosum natricum conexum, povidonum k 25, silica colloidalis anhydrica, magnesii stearas, Überzug: cera carnauba, lactosum monohydricum 6.39 mg, hypromellosum, triacetinum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 3.8 mg. - cytomegalovirus-(cmv) prophylaxe - synthetika
prevymis 240 mg/12 ml solution à diluer pour perfusion
msd merck sharp & dohme ag - letermovirum - solution à diluer pour perfusion - letermovirum 240 mg, hydroxypropylbetadexum 1800 mg, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 12 ml corresp. natrium 22.9 mg. - cytomegalovirus-(cmv)-prophylaxe - synthetika